Health ❯ Healthcare ❯ Drug Development

FDA Approval

Clinical Trials Cancer Therapies Oncology Drugs Tecelra Suzetrigine Targeted Therapy Oral Medications Orforglipron New Drug Application Intravesical Therapy Pivotal Trials Orphan Drug Designation Anktiva Hyperphagia Treatment AUVELITY Oncology REVTORPYK Next-Generation Medications

6 ARTICLES

2w ago

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

The decision lets doctors switch an aromatase inhibitor to the oral SERD camizestrant after a blood test finds an ESR1 resistance mutation, with confirmatory trials required.

5 ARTICLES

2mo ago

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

10 ARTICLES

3mo ago

CVS Caremark Restores Zepbound and Adds Lilly’s Foundayo to Standard Formularies

7 ARTICLES

4mo ago

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

8 ARTICLES

4mo ago

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

4 ARTICLES

7mo ago

‘Dancing Molecules’ Therapy Regenerates Nerves in Advanced Human Spinal Cord Organoids

7 ARTICLES

8mo ago

ImmunityBio Sets 30-Day FDA Submission After Positive Meeting on Anktiva Expansion

4 ARTICLES

9mo ago

Study Finds FDA Pivotal Trials Rarely Reflect U.S. Diversity as Black and Hispanic Enrollment Falls

4 ARTICLES

10mo ago

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

FDA Approval

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

CVS Caremark Restores Zepbound and Adds Lilly’s Foundayo to Standard Formularies

FDA Opens Early Access to KRAS-Targeting Pancreatic Cancer Pill After Strong Survival Data

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

‘Dancing Molecules’ Therapy Regenerates Nerves in Advanced Human Spinal Cord Organoids

ImmunityBio Sets 30-Day FDA Submission After Positive Meeting on Anktiva Expansion

Study Finds FDA Pivotal Trials Rarely Reflect U.S. Diversity as Black and Hispanic Enrollment Falls

Arcutis Turns First Profit on Zoryve Surge, Lifts Outlook as Stock Jumps

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma